Conference Reports for NATAP

Back

8th International Workshop on Pharmacology of HIV Therapy April 16-18, 2007 Budapest     8th International Workshop on Clinical Pharmacology of HIV Therapy - Written by Jennifer J. Kiser and Courtney V. Fletcher - (05/21/07)   Atazanavir Trough-Mutation Relation (GIQ Cutoff) Predicts Response Written for NATAP by Mark Mascolini - (04/24/07)   Lower Maraviroc Dose Needed With Darunavir Written for NATAP by Mark Mascolini - (04/24/07)   Pravastatin Levels 81% Higher With Darunavir/Ritonavir Written for NATAP by Mark Mascolini - (04/17/07)   Vicriviroc Levels Predict Early Salvage Response Written for NATAP by Mark Mascolini - (04/17/07)   Higher Tipranavir Levels in People With Liver Fibrosis Written for NATAP by Mark Mascolini - (04/17/07)   Maraviroc Levels Up One Third in People With Liver Impairment Written for NATAP by Mark Mascolini - (04/17/07)   Efavirenz Levels Normal in People Coinfected with HBV or HCV Written for NATAP by Mark Mascolini - (04/17/07)